Jama Pitman - Jan 17, 2023 Form 4 Insider Report for Deciphera Pharmaceuticals, Inc. (DCPH)

Signature
/s/ Jeffrey M. Held, Attorney-in-Fact
Stock symbol
DCPH
Transactions as of
Jan 17, 2023
Transactions value $
-$34,050
Form type
4
Date filed
1/19/2023, 03:06 PM
Previous filing
Jun 21, 2022
Next filing
Feb 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DCPH Common Stock Sale -$34K -1.6K -4.37% $21.24 35.1K Jan 17, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was to cover tax liabilities in the vesting of restricted stock.

Remarks:

Title: SVP, Regulatory, Quality, & Portfolio Management